Bevacizumab’s Role in Recurrent Ovarian Cancer

4 Views
administrator
administrator
07/01/23

Expert perspectives on bevacizumab’s role in recurrent ovarian cancer, particularly in light of recent PARP inhibitor strategies.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next